Coherus Biosciences Inc. (CHRS) Sank To An 11-Month Low On FDA News

Coherus Biosciences Inc. (CHRS) announced Monday morning that it has received a complete response letter from the FDA for its biologics license application for CHS-1701.

from RTT - Before the Bell http://ift.tt/2tgOm74
via IFTTT